⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20447769 | 0.98 | ALOX15 (0.42) | — | |
| Hydrochloric Acid SCHEMBL741807 | 0.98 | ALOX15 (0.42) | — | |
| SCHEMBL22441532 | 0.98 | — | — | |
| SCHEMBL571438 | 0.91 | SMN1; SMN2 (0.44) | — | |
| SCHEMBL2507803 | 0.91 | ALOX15 (0.41) | — | |
| SCHEMBL16111684 | 0.90 | ALOX15 (0.37) | — | |
| SCHEMBL1812214 | 0.89 | ALOX15 (0.39) | — | |
| Hydrochloric Acid SCHEMBL1279280 | 0.89 | SMN1; SMN2 (0.42) | — | |
| SCHEMBL1837607 | 0.89 | ALOX15 (0.39) | — | |
| Hydrochloric Acid SCHEMBL1279085 | 0.89 | ALOX15 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 422 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117903078-A | Amide derivative containing 3, 4-dichloro isothiazole, preparation method and application thereof | 南开大学 | 2024-04-19 | — | — | CN | claimed |
| US-20130005730-A1 | NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS | MEDIVIR AB (SE) | 2013-01-03 | — | — | US | claimed |
| EP-2499120-A1 | NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS | Novadex Pharmaceuticals AB (SE) | 2012-09-19 | — | — | EP | claimed |
| WO-2011056126-A1 | NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS | NOVADEX PHARMACEUTICALS AB (SE) | 2011-05-12 | — | — | WO | claimed |
| EP-0533832-B1 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | US SECRETARY UNITED STATES DEP (US) | 2002-11-20 | — | — | EP | claimed |
| US-6017957-A | AN AMINOCYCLOPROPANECARBOXYLIC ACID OR ESTER AS POTENT DRUG TREATING NERVOUS SYSTEM DISORDER EPILEPSY, STROKE, ANXIETY, ALZHEIMER'S DISEASE, PARKINSON DISEASE, GUAM ALS, DEMENTIA, AND LATHYRISM | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-01-25 | — | — | US | claimed |
| EP-0485431-B1 | PARTIAL AGONISTS OF THE STRYCHNINE INSENSITIVE GLYCINE MODULATORY SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX AS NEUROPSYCHOPHARMACOLOGICAL AGENTS | US HEALTH (US) | 1997-02-19 | — | — | EP | claimed |
| EP-0533832-A4 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | US COMMERCE (US) | 1993-04-28 | — | — | EP | claimed |
| EP-0533832-A1 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1993-03-31 | — | — | EP | claimed |
| EP-0485431-A4 | PARTIAL AGONISTS OF THE STRYCHNINE INSENSITIVE GLYCINE MODULATORY SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX AS NEUROPSYCHOPHARMACOLOGICAL AGENTS | US HEALTH (US) | 1992-08-12 | — | — | EP | claimed |
| EP-0485431-A1 | PARTIAL AGONISTS OF THE STRYCHNINE INSENSITIVE GLYCINE MODULATORY SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX AS NEUROPSYCHOPHARMACOLOGICAL AGENTS. | US HEALTH (US) | 1992-05-20 | — | — | EP | claimed |
| US-5086072-A | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-02-04 | — | — | US | claimed |
| WO-1991019493-A1 | TREATMENT OF MOOD DISORDERS WITH FUNCTIONAL ANTAGONISTS OF THE GLYCINE/NMDA RECEPTOR COMPLEX | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1991-12-26 | — | — | WO | claimed |
| WO-1991001729-A1 | PARTIAL AGONISTS OF THE STRYCHNINE INSENSITIVE GLYCINE MODULATORY SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR COMPLEX AS NEUROPSYCHOPHARMACOLOGICAL AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1991-02-21 | — | — | WO | claimed |
| US-12637478-B2 | Compound, preparation method thereof, and antibiotic composition comprising same | A&J SCIENCE CO., LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-20260109702-A1 | NOVEL GSPT PROTEIN DEGRADER AND APPLICATION THEREOF | GENOSCO INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4142732-B1 | METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-4965286-A | ACYLATED ALPHA-AMINE ACID ESTER | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-23 | — | — | US | disclosed |
| US-4372776-A | ARYLAMINOCYCLOPROPLY CARBOXYLATES; HARVESTING | SHELL OIL COMPANY (US) | 1983-02-08 | — | — | US | disclosed |
| EP-0051884-A1 | Amino-cyclopropyl-carboxylic-acid derivatives for the loosening of fruit and/or leaves on plants | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1982-05-19 | — | — | EP | disclosed |